EKSO BIONICS HOLDINGS INC (EKSO) Stock Income Statement
NASDAQ:EKSO - Nasdaq - US2826443010 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 17.54M | 17.93M | 18.28M | 12.91M | 11.25M | |||
| Cost Of Goods | 8.18M | 8.41M | 9.20M | 6.70M | 4.50M | |||
| Gross Profit | 9.37M | 9.51M | 9.08M | 6.21M | 6.75M | |||
| Operating Expenses | 19.83M | 19.97M | 24.19M | 21.77M | 20.58M | |||
| Research and Development | 3.73M | 3.87M | 5.03M | 3.63M | 2.75M | |||
| Selling, General, and Administrative Expenses | 16.10M | 16.10M | 19.17M | 18.14M | 17.83M | |||
| Operating Income | -10.46M | -10.46M | -15.11M | -15.56M | -13.83M | |||
| Interest Income/Expense | -274.00K | -1.23M | 110.00K | -810.00K | -1.01M | |||
| Other Income/Expense | 126.00K | 473.00K | -196.00K | 1.29M | 3.98M | |||
| Non Recurring Items | -180.00K | -109.00K | N/A | 0.00 | 1.10M | |||
| Income Before Taxes | -10.79M | -11.33M | -15.20M | -15.08M | -9.76M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -10.79M | -11.33M | -15.20M | -15.08M | -10.79M | |||
| EBITDA | -8.88M | -8.85M | -13.41M | -14.67M | -13.27M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.49 | -0.56 | -1.10 | -1.16 | -0.89 | |||
| Non GAAP EPS | -4.13 | -2.53 | -1.10 | -1.16 | -0.91 | |||
| Statistics | ||||||||
| Gross Profit Margin | 53.39% | 53.06% | 49.67% | 48.10% | 60.00% | |||
| Profit Margin | -61.51% | -63.21% | -83.14% | -116.81% | -95.91% | |||
| Operating Profit Margin | -59.64% | -58.35% | -82.67% | -120.53% | -122.93% | |||
All data in USD